Recently Posted Guidance Documents on Drugs and Labeling, New Animal Drug Application (NADA), Administrative / Procedural, Advertising

Drugs

3/13/2018 M7(R1) Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals To Limit Potential Carcinogenic Risk

Labeling, New Animal Drug Application (NADA)

3/12/2018  CVM GFI #240 Proprietary Names for New Animal Drugs

Guidance Document Search

• Search all FDA official guidance documents and other regulatory guidance